Andree Blaukat

Outlook Microsoft Office 365 WordPress.org Google Font API Nginx Mobile Friendly Apache Android Circle

drug discovery precision oncology biotechnology biotechnology research synthetic lethality biomarker discovery companion diagnostics alt cancers lof program tumor suppressor retinoblastoma 1 rb1 alternative lengthening of telomeres cancer therapies small molecule drug discovery first-in-class medicines precision medicine drug development cancer patients unmet medical need tumor-targeted treatments clinical validation poly-adp-ribose polymerase parp inhibitors cancer genomics oncology research novel biology pipeline development target identification in vitro pharmacology therapeutic strategies dna damage response cancer cell death genomic stability telomere integrity personalized cancer therapy research collaborations scientific validation academic partnerships oncology drug discovery molecular diagnostics cancer metabolism kinase signaling genomic testing fda-approved tests tumor agnostic therapies early-stage biotechnology biopharmaceutical innovation life sciences partnerships